Pittsburgh-based Mylan Pharmaceuticals will be the first company to produce a generic version of a popular blood thinner.
According to Philly.com, the FDA has approved generic form Plavix. Companies that submitted applications for generic approval will now be allowed to start production of the drug under its generic name, clopidogrel.
Plavix is used by millions of people who have a history of heart disease. And until now was produced and marketed by a partnership between Sanofi-Aventis and Bristol-Myers Squibb.
Consumers will begin to see a price reduction as more companies begin production over the next year.